Medical device startup developing diabetes-management technologies, including the SteadiSet insulin pump infusion set with a kink-resistant, soft multi-port cannula and user-friendly insertion device
Medical device startup developing diabetes-management technologies, including the SteadiSet insulin pump infusion set with a kink-resistant, soft multi-port cannula and user-friendly insertion device. Its longer-term goal was a fully implantable automated insulin delivery system combining continuous glucose monitoring, insulin infusion, and closed-loop control. Acquired by Tandem Diabetes Care in 2022.